Sarepta Therapeutics, Inc. (SRPT)
16.80
-0.16
(-0.94%)
USD |
NASDAQ |
May 22, 16:00
16.83
+0.03
(+0.18%)
After-Hours: 20:00
Sarepta Therapeutics EPS Diluted (Quarterly) : 2.878 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| PTC Therapeutics, Inc. | -0.034 |
| Keros Therapeutics, Inc. | -1.208 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| REGENXBIO, Inc. | -1.718 |
| Biogen, Inc. | 2.153 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 330.96M |
| Revenue (Quarterly) | 730.80M |
| Total Expenses (Quarterly) | 399.84M |
| Enterprise Value | 2.157B |
| Gross Profit Margin (Quarterly) | 83.67% |
| Profit Margin (Quarterly) | 45.29% |
| Earnings Yield | -5.74% |
| Operating Earnings Yield | 0.06% |
| Normalized Earnings Yield | -1.678 |